Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

HLA DQ2/DQ8 haplotypes and the clinical presentation of patients with celiac disease.

Created on 29 Sep 2025

Authors

Alicia Antunes, Fabiana Andrade, Lorete Maria da Silva Kotze, Renato Nisihara

Published in

Revista espanola de enfermedades digestivas. Sep 29, 2025. Epub Sep 29, 2025.

Abstract

Celiac disease (CD) is a chronic condition triggered by gluten consumption in genetically predisposed individuals, with approximately 95% of CD patients carrying the HLA-DQ2 or DQ8 risk haplotypes. In addition to genetic susceptibility, recent evidence suggests that these haplotypes may influence the clinical presentation and severity of CD. However, evidence on this topic remains scarce, and the impact of HLA-DQ2 and DQ8 haplotypes on CD is not yet fully established. The present study investigated the relationship between HLA-DQ2 and DQ8 haplotypes and gastrointestinal symptoms in CD patients from Southern Brazil, treated in a private clinical setting. All patients were diagnosed with CD based on positive serological tests (anti-endomysial IgA) and confirmed by histological findings in duodenal biopsies (Marsh classification). The presence of haplotypes was determined by DNA typing using polymerase chain reaction (PCR), and clinical data were collected at the initial consultation, prior to the initiation of a gluten-free diet.

PMID:
41020955
Bibliographic data and abstract were imported from PubMed on 29 Sep 2025.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 33
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement